FindTrial
Sign In

A retrospective study to explore the best biomarkers for the use of antibiotics in COPD exacerbations

A retrospective study to explore the best biomarkers for the use of antibiotics in COPD exacerbations

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039379
Enrollment
Unknown
Registered
2020-10-25
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

case series:Nil

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 years; 2. AECOPD diagnosed according to the 2020 cold guidelines.

Exclusion criteria

Exclusion criteria: 1. Patients with tuberculosis, tumor, bronchiectasis, pulmonary fibrosis and other chronic respiratory diseases; 2. Patients with severe cardiovascular diseases, primary diseases of liver, kidney and blood system; 3. Patients with asthma, allergic rhinitis, eczema, eosinophilic pneumonia and other diseases that may lead to eosinophilia.

Design outcomes

Primary

MeasureTime frame
Eosinophilia;—

Countries

China

Contacts

Public ContactLiu Wei

West China Hospital of Sichuan University

576595276@qq.com+86 18583678610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026